Amphotericin B
两性霉素B
Report date: 2026/05/02 20:00:18
NMEQIDP
Base Information
Drug NameAmphotericin B
Drug Alias Name +[22]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[9]
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date1958/03/18
Country/Territory +[10]
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A
Develop Information
Active CompaniesRadboud University Medical CenterClinigen LtdPostgraduate Institute Of Medical Education And Research +[5]
Inactive CompaniesBristol Myers Squibb SrlcompanyUniversity Of PittsburghBanaras Hindu University Medical Alumni Association Of North America +[8]
Active Indications +[4]
Inactive Indications +[5]